Phio Pharmaceuticals Corp. (PHIO) Total Assets by Year
Phio Pharmaceuticals Corp. closed fiscal year 2025 with $21.5M in total assets, $1.3M in total liabilities and $20.1M in shareholder equity. This represents an increase of 274.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Phio Pharmaceuticals Corp. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PHIO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $21.5M+274.5% | $5.7M-38.7% | $9.4M-26.9% | $12.8M-49.1% | $25.2M+59.9% | $15.7M+95.8% | $8.0M-47.5% | $15.3M+273.9% | $4.1M-69.4% | $13.4M+20.1% | $11.2M+21.4% | $9.2M-38.5% | $14.9M+167.1% | $5.6M+230.1% | $1.7M |
| Total Liabilities | $1.3M+32.0% | $1.0M-37.9% | $1.6M-17.2% | $2.0M-39.0% | $3.2M+19.0% | $2.7M+18.8% | $2.3M+31.4% | $1.7M-23.0% | $2.3M-10.9% | $2.5M+12.0% | $2.3M-64.8% | $6.4M-35.5% | $10.0M-12.6% | $11.4M+401.2% | $2.3M |
| Total Equity | $20.1M+326.6% | $4.7M-38.9% | $7.7M-28.7% | $10.8M-50.6% | $21.9M+68.5% | $13.0M+126.5% | $5.7M-57.7% | $13.6M+640.8% | $1.8M-83.1% | $10.9M+22.1% | $8.9M+223.9% | $2.7M-44.5% | $4.9M+184.6% | -$5.8M-894.9% | -$587K |
PHIO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.3M+26.6% | $17.4M+29.6% | $21.5M+274.5% | $11.5M+96.2% | $11.3M+113.4% | $13.4M+96.1% | $5.7M-38.7% | $5.9M-38.5% | $5.3M-56.9% | $6.9M-29.4% | $9.4M-26.9% | $9.5M-39.6% |
| Total Liabilities | $1.7M+41.4% | $950K-25.2% | $1.3M+32.0% | $1.7M+81.3% | $1.2M-20.8% | $1.3M+1.7% | $1.0M-37.9% | $919K-60.5% | $1.5M-36.3% | $1.2M-47.9% | $1.6M-17.2% | $2.3M+2.7% |
| Total Equity | $12.6M+24.8% | $16.5M+35.3% | $20.1M+326.6% | $9.8M+98.9% | $10.1M+167.6% | $12.2M+117.2% | $4.7M-38.9% | $4.9M-31.4% | $3.8M-61.9% | $5.6M-23.3% | $7.7M-28.7% | $7.2M-46.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Phio Pharmaceuticals Corp. financials
Frequently Asked Questions
What was Phio Pharmaceuticals Corp.'s total assets in fiscal year 2025?
Phio Pharmaceuticals Corp. closed fiscal year 2025 with $21.5M in total assets, $1.3M in total liabilities and $20.1M in shareholder equity.
How fast is Phio Pharmaceuticals Corp.'s total assets growing?
Phio Pharmaceuticals Corp. (PHIO) total assets rose by 274.5% year over year, from $5.7M to $21.5M in fiscal year 2025.
How has Phio Pharmaceuticals Corp.'s total assets changed over the years?
Across the 15 fiscal years this page covers, Phio Pharmaceuticals Corp. (PHIO) total assets went from $1.7M in fiscal year 2011 to $21.5M in fiscal year 2025.
What was Phio Pharmaceuticals Corp.'s total assets in the most recent quarter?
Phio Pharmaceuticals Corp. (PHIO) reported $14.3M in total assets in Q2 2026. This represents an increase of 26.6% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Phio Pharmaceuticals Corp. (PHIO) reported on that line in every period on record.